1Mby1M AI Investor Forum: Angel Investor Raju Reddy (Part 2)

Sramana Mitra: Software development is getting hugely streamlined, right? The co-pilots are becoming extremely effective. So, you don’t need as many people on the software services side as well. There are a lot of co-pilot products that are getting sold into that business. So, there’s a whole market emerging out of efficiency in the software

Read Full Article »

1Mby1M AI Investor Forum: Angel Investor Raju Reddy (Part 1)

Entrepreneur, Angel Investor, and Board Member Raju Reddy discusses his AI investment thesis.

Building a New Age AI Services Company: Cognida CEO Feroze Mohammed (Part 1)

IT Services is going through a profound shift. Huge opportunity for more companies like Palantir to be built. This discussion parses the nuances of building such ventures. Needless to say, VC money is now going to flood into this model.

AI Investor Forum: Gus Tai on AI in Healthcare (Part 1)

Gus Tai, Investor, Board Member and Retired General Partner at Trinity Ventures, discusses AI in Healthcare startups. Fascinating, comprehensive discussion with concrete pointers.

AI Investor Forum: Gus Tai on AI in Education (Part 1)

Gus Tai, Investor, Board Member and Retired General Partner at Trinity Ventures, discusses ideas and opportunities in Education with an AI-augmented framework.

666th 1Mby1M Entrepreneurship Podcast with Investor Gus Tai (Part 3, 2024)

Gus Tai, Investor, Board Member and Retired General Partner at Trinity Ventures, discusses AI in Healthcare startups. Fascinating, comprehensive discussion with concrete pointers.

1Mby1M Virtual Accelerator AI Investor Forum: With Mo Islam, Partner at Threshold Ventures (Part 3)

Sramana Mitra: Could you talk a little bit about the financing journey of a company that has a 10-15 year lifecycle?

1Mby1M Virtual Accelerator AI Investor Forum: With Mo Islam, Partner at Threshold Ventures (Part 2)

Sramana Mitra: So let’s double click down on drug discovery. It’s something that I’ve been spending time on as well. What have you invested in and how are you thinking about AI-enabled drug discovery? What’s the criteria of what you want to invest in and what have you invested in?